v3.26.3
Condensed Consolidated Interim Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities    
Net loss $ (25,227,204) $ (20,704,388)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 155,987 141,743
Gain on sale of property and equipment (11,629) 0
Stock-based compensation expense 2,493,330 2,373,711
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 202,158 (419,410)
Accounts payable and accrued liabilities 734,322 246,561
Other non-current assets (667,330) 0
Net cash used in operating activities (22,320,366) (18,361,783)
Investing activities    
Purchases and advances for property and equipment (1,620,987) (110,891)
Proceeds from the sale of property and equipment 13,000 0
Purchases of mineral rights and properties (750,030) (185,353)
Net cash used in investing activities (2,358,017) (296,244)
Financing activities    
Proceeds from exercise of stock options 1,281,125 96,000
Proceeds from exercise of warrants 10,898,838 2,960,157
Payments of employee income taxes on performance stock units ("PSUs"), restricted stock units ("RSUs"), stock options, and shares issued for compensation (283,573) (785,458)
Principal repayment on finance lease liability (2,000) 0
Net cash provided by financing activities 87,144,790 42,271,810
Net change in cash and cash equivalents 62,466,407 23,613,783
Cash and cash equivalents, beginning of period 29,686,451 9,408,270
Cash and cash equivalents, end of period 92,152,858 33,022,053
Non-cash investing and financing activities:    
Reduction of additional paid in capital from amortization and expiration of deferred ATM Program costs (25,727) (246,671)
Common stock issued for bonuses 0 113,959
Supplemental cash flow information:    
Interest paid on finance lease liability 38,000 0
ATM Program    
Financing activities    
Proceeds from sale of common stock, net of issuance costs 3,539,373 7,316,230
Public offering    
Financing activities    
Proceeds from sale of common stock, net of issuance costs $ 71,711,027 $ 32,684,881